Breast Cancer Clinical Trials

Showing 1621-1640 of 4,817 trials

Analysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer

NCT03205761

This is a multicenter single-arm phase II clinical trial to evaluate the efficacy and safety of olaparib in patients diagnosed of advanced triple negative breast cancer (TNBC) with methylation of BRCA1 and/or BRCA2 promoters assessed in DNA from metastatic lesions and absence of BRCA1 and 2 germline mutations.

Advanced Breast Cancer

Spanish Breast Cancer Research Group11 participantsStarted Oct 2017

Badalona, Barcelona, Spain • Reus, Tarragona, Spain • Barcelona, Spain +13 more locations

RECRUITING

Molecular Biomarkers of Response to Radiation Therapy in Breast Cancer

NCT06648148

The purpose of this study is to identify potential genetic and other molecular biomarkers of response to radiation therapy in breast cancer that may help to personalize breast cancer radiation treatment in the future.

Breast CancerRadiotherapy Side Effect

Institute of Oncology Ljubljana200 participantsStarted Nov 2019

Ljubljana, Slovenia

Analysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer

Molecular Biomarkers of Response to Radiation Therapy in Breast Cancer

Related Searches

Milademetan in Advanced/Metastatic Solid Tumors

Cellular Immune Responses in Triple-negative Breast Cancer - High Throughput Immunogenetic Studies

Effectiveness of an N-acetylcysteine and Urea-based Cream in Prevention of Capecitabine-induced HAND-foot Syndrome in Breast Cancer Patients

Does Type of Anesthesia Influence Inflammation Change After Breast Surgery?

A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer

Clinical Classification of Pain in Breast Cancer Survivors

Neoadjuvant Chemotherapy + PD-1 Inhibitor+Different Radiotherapy Fractionations for HR+/HER2- Breast Cancer

The Efficacy and Safety of Different Combination Regimens of Inetetamab in First-line Treatment of HER2 Positive Metastatic Breast Cancer

The Safety and Efficacy of Multimodal Thermal Therapy in the Treatment of Early-stage Invasive Breast Cancer

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant

Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer

Brevera™ Breast Biopsy System Data Collection Study

Autologous Nerve Graft Breast Reconstruction Neurotization

Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.

SNF Platform Study of HR+/ HER2-advanced Breast Cancer

A Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With Breast Cancer Gene (BRCA) Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast Cancer

The Mid-point Transverse Process to Pleura Block Versus Serratus Anterior Plane Block for Postoperative Analgesia After Modified Radical Mastectomy